[32] investigated the effect of 2 different diets on Alzheimer’s disease risk modulation via cerebrospinal fluid and observed changes in APOE and F2-isoprostane concentrations; Aβ40, Aβ42, tau protein, and phospho-tau, however, remained unaffected. The gene discussed is MAPT; the disease is Alzheimer disease.